EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming

Helmut Bischof iD, Selina Maier, Piotr Koprowski, Bogusz Kulawiak iD, Sandra Burgstaller iD, Joanna Jasińska, Kristian Serafimov, Monika Zochowska, Dominic Gross, Werner Schroth, Lucas Matt, David Arturo Juarez Lopez und 11 weitere

eLife · 29.05.2024 · 12

DOI: 10.7554/elife.92511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 29.05.2024. Verfasst von Helmut Bischof und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Interfaculty Centre for Pharmacogenomics and Pharma Research, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alterations in the function of K + channels such as the voltage- and Ca 2+ -activated K + channel of large conductance (BK Ca ) reportedly promote breast cancer (BC) development and progression. Underlying molecular mechanisms remain, however, elusive. Here, we provide electrophysiological evidence for a BK Ca splice variant localized to the inner mitochondrial membrane of murine and human BC cells (mitoBK Ca ). Through a combination of genetic knockdown and knockout along with a cell permeable BK Ca channel blocker, we show that mitoBK Ca modulates overall cellular and mitochondrial energy production, and mediates the metabolic rewiring referred to as the ‘Warburg effect’, thereby promoting BC cell proliferation in the presence and absence of oxygen. Additionally, we detect mitoBK Ca and BK Ca transcripts in low or high abundance, respectively, in clinical BC specimens. Together, our results emphasize, that targeting mitoBK Ca could represent a treatment strategy for selected BC patients in future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansAnimalsMiceCell Line, TumorCell ProliferationMitochondriaLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMitochondrial MembranesFemaleEnergy Metabolism

Stichwörter der Autor:innen

K+ channelsKcnma1Slo1Warburg effectbiosensorsbreast cancercancer biologycell biologyhumanmetabolic reprogrammingmitoBKCamouse

Substanzen

Large-Conductance Calcium-Activated Potassium Channel alpha SubunitsKCNMA1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
  • NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Center for Medical Research, CF Bioimaging, Medical University of Graz, Graz, Austria.
  • Institute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany.

ORCID-Profile: Helmut Bischof, Bogusz Kulawiak, Sandra Burgstaller, Irina Bonzheim, Andreas L Birkenfeld, Roland Malli, Piotr Bednarczyk, Adam Szewczyk, Robert Lukowski

Förderung

  • Deutsche Forschungsgemeinschaft
  • Interfaculty Centre for Pharmacogenomics and Pharma Research
  • Austrian Science Fund
  • Narodowe Centrum Nauki
  • Fritz Thyssen Stiftung
  • Robert Bosch Stiftung

Zitieren

APA

Bischof, H., Maier, S., Koprowski, P., Kulawiak, B., Burgstaller, S., Jasińska, J., Serafimov, K., Zochowska, M., Gross, D., Schroth, W., Matt, L., Juarez Lopez, D. A., Zhang, Y., Bonzheim, I., Büttner, F. A., Fend, F., Schwab, M., Birkenfeld, A. L., Malli, R., …, & Lukowski, R. (2024). mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming. eLife, 12. https://doi.org/10.7554/elife.92511

Vancouver

Bischof H, Maier S, Koprowski P, Kulawiak B, Burgstaller S, Jasińska J, et al. mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming. eLife. 2024;12. doi:10.7554/elife.92511

BibTeX
@article{Bischof2024,
  author = {Bischof, Helmut and Maier, Selina and Koprowski, Piotr and Kulawiak, Bogusz and Burgstaller, Sandra and Jasińska, Joanna and Serafimov, Kristian and Zochowska, Monika and Gross, Dominic and Schroth, Werner and Matt, Lucas and Juarez Lopez, David Arturo and Zhang, Ying and Bonzheim, Irina and Büttner, Florian A and Fend, Falko and Schwab, Matthias and Birkenfeld, Andreas L and Malli, Roland and Lämmerhofer, Michael and Bednarczyk, Piotr and Szewczyk, Adam and Lukowski, Robert},
  title = {mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming},
  journal = {eLife},
  year = {2024},
  volume = {12},
  doi = {10.7554/elife.92511}
}
Kostenlos starten →